pfizer - Search News

News

FDA, Pfizer and COVID-19

FDA may revoke Pfizer COVID-19 vaccine authorization for kids under certain age

The Food and Drug Administration could pull Pfizer's coronavirus vaccine emergency authorization for children under age 5.

WFSB on MSN · 1d

FDA considering pulling authorization of Pfizer’s COVID-19 vaccine for healthy children under 5

The Food and Drug Administration is considering pulling its authorization of Pfizer’s COVID-19 vaccine for healthy children under five, and it could leave many kids unprotected from the virus.

USA TODAY on MSN · 2d

FDA may revoke Pfizer COVID-19 shot for young, healthy children.

Parents won't be able to vaccinate healthy children 6 months to 5 years old if the FDA pulls Pfizer's COVID-19 vaccine authorization.

11hon MSN

Pfizer fails in late-stage trial for sickle cell disease therapy

Pfizer (PFE) stock slips as a Phase 3 trial failure for its sickle cell disease therapy inclacumab marks the latest setback ...

PharmExec7h

Pfizer’s Sickle Cell Treatment Fails Phase 3 Study

Pfizer's inclacumab fails Phase III study for sickle cell disease, disappointing the community while the company remains ...

BioPharma Dive10h

Precigen wins immunotherapy approval; Pfizer sickle cell drug fails trial

The FDA’s announcement of Papzimeos’ approval contained an unusual quote from newly reinstated CBER director Vinay Prasad. Elsewhere, Eli Lilly and Superluminal Medicines struck a deal.

9hon MSN

Pfizer's sickle-cell treatment efforts falter as drug fails study

By Padmanabhan Ananthan (Reuters) -In the latest setback for Pfizer's sickle cell anemia treatments, experimental drug ...

Pfizer looks to expand ADC use after positive bladder cancer data

Padcev, an antibody-drug conjugate which Pfizer acquired via its $43 billion Seagen deal, could help people who don’t qualify ...

mlive on MSN2d

‘Potential exposure’ at Portage Pfizer plant sends people to hospital, MIOSHA investigating

Several workers reported symptoms of being exposed to a substance and some were taken to the hospital. The state is ...

11h

Pfizer's sickle cell drug fails main goal in late-stage trial

Pfizer said on Friday that its experimental sickle cell disease drug failed to meet the main goal in a late stage trial in ...

2don MSN

3 Reasons Pfizer's 7%-Yielding Dividend Is Getting Safer

Pfizer (NYSE: PFE) is a case in point, with its forward dividend yield of 7%. Although the stock is a favorite for many ...

7hon MSN

Pfizer Inc. (PFE) Comes Up With A Good Thing But No One Cares, Laments Jim Cramer

We recently published 10 Stocks Jim Cramer Discussed As He Questioned Official Data. Pfizer Inc. (NYSE:PFE) is one of the ...

10hon MSN

Pfizer's sickle cell drug fails late-stage trial

Pfizer's experimental drug to treat sickle cell anemia failed to meet the main goal in a late stage trial, the drugmaker said ...

14hon MSN

After a Strong Quarterly Result, Is It Finally Safe to Buy Pfizer Stock Again?

Pfizer ( PFE -0.18%) was a hot stock during the pandemic, but it has been crashing in recent years. The company's COVID ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results